Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects
Latest Information Update: 04 Dec 2019
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders
- Focus Adverse reactions
- Acronyms NISANIK
- Sponsors TETEC
- 02 Dec 2019 Status changed from active, no longer recruiting to completed.
- 04 Jan 2019 Planned End Date changed from 1 Sep 2019 to 1 Nov 2019.
- 04 Jan 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Nov 2019.